LOX and familial pancreatic carcinoma: Interestingly, in one study, the combination of LOX-PP with the chemotherapeutic agent doxorubicin in breast and pancreatic cancer cells in vitro showed an enhanced cytotoxic effect of doxorubicin when the cells were first sensitize by incubation with LOX-PP (105).